Access comprehensive trade data for Munani Pharmaceutical with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Eximpedia analyzes Munani Pharmaceutical export and import records, including data from 5 buyers and 0 suppliers. We provide an intelligence report of Munani Pharmaceutical that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
No Pay, No Delay - 5 days Your Way!
Learn How our platform works in just 20 minutes!
Free Import-Export Sample data-One Click Away!
Munani Pharmaceutical export markets
Explore the INDIA export market with monthly export values, major importers, HS Codes, key ports, top suppliers, and competitors
HS CODE | USD VALUE | SHIPMENTS | % |
---|---|---|---|
30049099 | 0.16 | 273 | 39.11 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
30049049 | 0.05 | 47 | 6.73 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
30021500 | 0.03 | 8 | 1.15 |
HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
30043919 | 0.02 | 13 | 1.86 |
MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
30021290 | 0.02 | 15 | 2.15 |
HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR |
COUNTRY | USD VALUE | SHIPMENTS | % |
---|---|---|---|
MALAYSIA | 0.13 | 328 | 46.99 |
UNITED ARAB EMIRATES | 0.12 | 323 | 46.28 |
ITALY | 0.06 | 15 | 2.15 |
JAPAN | 0.04 | 15 | 2.15 |
AUSTRALIA | 0.01 | 1 | 0.14 |
PORTS | USD VALUE | SHIPMENTS | % |
---|---|---|---|
BOMBAY AIR CARGO | 0.39 | 698 | 100.00 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
HETERO LABS LIMITED | 724.57 | 9722 |
SUN PHARMACEUTICAL INDUSTRIES LIMITED | 768.40 | 26398 |
AUROBINDO PHARMA LIMITED | 794.73 | 31575 |
ZYDUS LIFESCIENCES LIMITED | 885.74 | 14666 |
MYLAN LABORATORIES LIMITED | 1293.16 | 16278 |
COMPANY | USD VALUE | SHIPMENTS |
---|---|---|
LUPIN PHARMACEUTICALS INC | 270.58 | 1112 |
ZYDUS PHARMACEUTICALS USA INC | 373.15 | 842 |
EVERSANA LIFE SCIENCE SERVICES | 400.00 | 4639 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 436.72 | 747 |
AUROBINDO PHARMA USA INC | 441.93 | 5824 |
If you are looking to establish relationship with Munani Pharmaceutical Automation you can save time by getting access to the key decision makers and get a detailed report.
Discover the Munani Pharmaceutical with product description, import values, quantities, exporter name, country of origin and key destinations.
HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
---|---|---|---|---|---|---|
30045010 | CONT. MEDICINES HARMLESS PHARMA.PRODUCTS, DETAILS AS PER ATTA.EXP.INV.MPE2324067 DT 24.11.2023TENECTEPLASE KIT 40MG I | INDIA | ITALY | 10 | ||
30049046 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023DACTINOMYCIN 0.5MG INJ | INDIA | MALAYSIA | 140 | ||
30049049 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023PROCARBAZINE HCL 50MG | INDIA | MALAYSIA | 14 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023MELATONIN 3MG TABLETS | INDIA | MALAYSIA | 60 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023GANCICLOVIR OPHTHALMIC | INDIA | MALAYSIA | 15 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023RASBURICASE 1.5MG INJE | INDIA | MALAYSIA | 10 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023GLYCOPYRROLATE 1MG TAB | INDIA | MALAYSIA | 150 | ||
30041010 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023PENICILLAMINE 250MG CA | INDIA | MALAYSIA | 44 | ||
30021500 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023NIMOTUZUMAB 50MG 10ML | INDIA | MALAYSIA | 2 | ||
30049021 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023LEVAMISOLE HCL 50MG TA | INDIA | MALAYSIA | 3 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023RIBAVIRIN 200MG CAPSUL | INDIA | MALAYSIA | 12 | ||
30021290 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023DIPHTHERIA ANTITOXIN 1 | INDIA | MALAYSIA | 100 | ||
30049055 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023DAPSONE 100MG TABLETS | INDIA | MALAYSIA | 15 | ||
30041010 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023PENICILLAMINE 250MG CA | INDIA | MALAYSIA | 46 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023SUXAMETHONIUM 100MG/2M | INDIA | MALAYSIA | 7 | ||
30063000 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023INDOCYANINE GREEN 25MG | INDIA | MALAYSIA | 10 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS,DETAILS AS PER ATTA. EXP. INV.MPE2324049 DT10.10.2023TESTOSTERONE ENANTHATE | INDIA | MALAYSIA | 10 | ||
30049099 | CONT.MEDICINES HARMLESS PHARM.PRODUCTS,DETAILS AS PER ATTA.EXP.INV.MPE2324058DT31.10.2023EMTRICITABINE 200MG+TENOFO | INDIA | JAPAN | 1000 | ||
30021500 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS: RECOMBINANT HUMAN INTERFERONALFA 2B 5MIU INJECTION | INDIA | AUSTRALIA | 1134 | ||
30049099 | CONT. MEDICINES HARMLESS PHARMA. PRODUCTS, DETAILS AS PER ATTA. EXP. INV.NOMPE2324042 DT15.09.2023-ALTEPLASE 50MG INJE | INDIA | ITALY | 29 |
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
See all that you can accomplish with Eximpedia